Business NewsPR NewsWire • MBM ScienceBridge GmbH Negotiates License Agreement Between the Georg-August-University Gottingen, Universitatsmedizin, the University of Regensburg, and the UK's Medical Research Council Technology for a New Therapy of Inflammatory and Immune Disea

MBM ScienceBridge GmbH Negotiates License Agreement Between the Georg-August-University Gottingen, Universitatsmedizin, the University of Regensburg, and the UK's Medical Research Council Technology for a New Therapy of Inflammatory and Immune Disea

MBM ScienceBridge GmbH Negotiates License Agreement Between the Georg-August-University Gottingen, Universitatsmedizin, the University of Regensburg, and the UK's Medical Research Council Technology for a New Therapy of Inflammatory and Immune Disea

LONDON and GOTTINGEN, Germany, January 12 /PRNewswire/ -- Reference MRCT: MRCT120110 Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentalli

View More : http://www.prnewswire.com/news-releases/mbm-sciencebridge-gmbh-negotiates-license-agreement-between-the-georg-august-uni...
Releted News by prnewswire
LatinFinance to Hold 2nd Latin America Mid-East Investors Forum on April 26-27, 2010, in Abu Dhabi
Ridge Global Names Steve Kohler to Lead Corporate Strategy and Growth
MBM ScienceBridge GmbH Negotiates License Agreement Between the Georg-August-University Gottingen, Universitatsmedizin, the University of Regensburg, and the UK's Medical Research Council Technology for a New Therapy of Inflammatory and Immune Disea
Autonomy's End-To-End eDiscovery Platform Receives Top Honors at Sixth Annual Law Technology News Awards
Monext, Oney Portugal's Trustworthy Partner for Managing the Retail Cards of the Group's Related Companies